We demonstrated that T cells stimulated with TriMixDCs and TetraMixDCs expressing Melan-A/MART-1 (A27L) could kill 624-MEL cells and inhibit tumor growth, which was in contrast to CD8+ T cells stimulated with moDCs co-electroporated with MelanA/MART-1 (A27L) mRNA and control mRNA (Figure 7F). Here, CD8A is linked to neoplasm.